Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.


About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/164363
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/164363
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.


WILLIAM SANDBORN

Listed Specialty: Gastroenterology
200 W ARBOR DR, SAN DIEGO, CA, 92103-9001

2018 Payments: At a Glance

131

payments

$157,472

payment total

22

companies paid this doctor

Types of Payments

Category Payments Payment Value
Consulting
31 $112K
Promotional Speaking/Other
24 $25,469
Travel and Lodging
28 $15,734
Food and Beverage
48 $3,947

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments
XELJANZ

drug

$65,710
Payments with no listed product

N/A

$61,143
STELARA

drug

$10,830
REMICADE

drug

$7,805
SIMPONI

drug

$7,805
HUMIRA

drug

$6,103
ENTYVIO

drug

$4,613
CLENPIQ

drug

$3,549
OZANIMOD

drug

$2,206
APRISO

drug

$2,000
UCERIS

drug

$2,000
INFLECTRA

drug

$1,300
FLOSEAL

drug

$18
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details

When How Much Related To What For From Third Party Payee
May 21, 2018 $29,375 XELJANZ Consulting PFIZER INC. REGENTS OF THE UNIVERSITY OF
May 14, 2018 $13,438 XELJANZ Consulting PFIZER INC. REGENTS OF THE UNIVERSITY OF
May 22, 2018 $9,063 No Listed Product Consulting THERAVANCE BIOPHARMA INC.
Apr 11, 2018 $8,315 No Listed Product Travel and Lodging GENENTECH, INC.
May 31, 2018 $6,875 No Listed Product Promotional Speaking/Other ALLERGAN INC.
Sep 6, 2018 $6,250 XELJANZ Consulting PFIZER INC. THE REGENTS UNIV OF CALIFORNIA
May 24, 2018 $6,250 SIMPONI STELARA REMICADE Consulting JANSSEN BIOTECH, INC. The Regents Of The Univ Of California
Jan 29, 2018 $5,188 No Listed Product Consulting OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Mar 29, 2018 $5,000 No Listed Product Consulting JANSSEN RESEARCH & DEVELOPMENT, LLC REGENTS OF THE UNIVERSITY OF CALIFO RNIA
Aug 23, 2018 $5,000 HUMIRA Consulting ABBVIE, INC. Regents of The Univ of California
Jun 26, 2018 $5,000 No Listed Product Consulting ELI LILLY AND COMPANY REGENTS OF THE UNIVERSITY OF CALIFORNIA
Feb 6, 2018 $3,090 CLENPIQ Consulting FERRING PHARMACEUTICALS INC.
May 7, 2018 $3,000 No Listed Product Consulting PROMETHEUS LABORATORIES INC.
Dec 21, 2018 $3,000 No Listed Product Consulting KYOWA HAKKO KIRIN CO., LTD
Jul 26, 2018 $2,188 OZANIMOD Consulting CELGENE CORPORATION
Aug 21, 2018 $2,000 XELJANZ Promotional Speaking/Other PFIZER INC. Regents of the University of California University
Feb 22, 2018 $2,000 APRISO UCERIS Promotional Speaking/Other SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC UC Regents
Aug 21, 2018 $2,000 XELJANZ Promotional Speaking/Other PFIZER INC. Regents of the University of California University
Aug 21, 2018 $2,000 XELJANZ Promotional Speaking/Other PFIZER INC. Regents of the University of California University
Dec 26, 2018 $1,875 STELARA Consulting JANSSEN BIOTECH, INC. Regents Of The Univ Of California

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/164363

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.